The extracellular matrix metabolites play a critical role in wound contraction and tissue regeneration, as highlighted in several studies (Zhao et al., 2015)
The result is a focused, high-impact portfolio that sets the gold standard in efficacy, commands premium pricing, and drives blockbuster salesOzempic and Wegovy alone raked in DKK 120 billion (~$17 billion) and DKK 58 billion (~$8 billion) in 2024
Therapeutic use of this peptide is now being explored in both topical and injectable forms as a means to reverse or mitigate these age-related changes
GLP-1 Receptor Pathway - Reduces hunger drive centrally (hypothalamus, brainstem) - Decreases the reward value of food (mesolimbic system) - Enhances glucose-dependent insulin secretion - Slows gastric emptying Amylin Receptor Pathway - Induces satiety through the area postrema and NTS - Activates POMC neurons (pro-satiety) and suppresses NPY/AgRP neurons (pro-hunger) in the arcuate nucleus - Additional gastric emptying delay through distinct neural circuits - Suppresses post-prandial glucagon secretion - May contribute to leptin resensitization The combination of these two pathways produces what researchers describe as broader modulation of neuroendocrine appetite control meaning amycretin hits more of the biological switches that drive eating behavior than a GLP-1-only drug can reach
Choline supplements: An update
Portrait has a nationwide network of licensed Medical Directors with built-in compliance tools that help you stay on top of new rules
